UPDATE: Barclays Capital Downgrades Ameren Following Outperformance

Loading...
Loading...
In a report published Tuesday, Barclays Capital analyst Gregg Orrill downgraded the rating on
AmerenAEE
from Overweight to Equal-Weight, but raised the price target from $38.00 to $41.00. In the report, Barclays Capital noted, “We are lowering our rating to Equal Weight from Overweight following outperformance year-to-date (+6.3% versus the XLU) and the last 6 months (+12.8%). We believe AEE's premium multiple to Regulateds is justified, but we forecast little upside potential to our new $41 target ($38 previously). Our new target reflects a 6% big cap utility premium of the 2015 average P/E of 15.0x versus 14.0x previously and an increase in our EPS estimate to $2.60 from $2.57. On the 2/21 earnings call AEE gave guidance of 7-10% EPS growth and $2.25-$2.45 for 2014, which was ahead of expectations. "It is supported by 6% ratebase growth including 28% from transmission through 2018. We like AEE's business mix and commitment to dividend growth. The EPS guidance for 2014 was $2.25-$2.45 and implied at $2.40-$2.65 for 2015. We are fine-tuning our EPS estimates to $2.33 for 2014 and $2.60 for 2015 from $2.29/$2.57, respectively.” Ameren closed on Monday at $40.90.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorDowngradesAnalyst RatingsBarclays CapitalGregg Orrill
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...